WO1993020829A1 - Methods for retarding blister formation by use of cyanoacrylate adhesives - Google Patents

Methods for retarding blister formation by use of cyanoacrylate adhesives Download PDF

Info

Publication number
WO1993020829A1
WO1993020829A1 PCT/US1993/003716 US9303716W WO9320829A1 WO 1993020829 A1 WO1993020829 A1 WO 1993020829A1 US 9303716 W US9303716 W US 9303716W WO 9320829 A1 WO9320829 A1 WO 9320829A1
Authority
WO
WIPO (PCT)
Prior art keywords
cyanoacrylate adhesive
adhesive
carbon atoms
cyanoacrylate
skin
Prior art date
Application number
PCT/US1993/003716
Other languages
French (fr)
Inventor
Leonard V. Barley, Jr.
Original Assignee
Medlogic, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medlogic, Inc. filed Critical Medlogic, Inc.
Publication of WO1993020829A1 publication Critical patent/WO1993020829A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S526/00Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S526/936Physiological use, e.g. pharmaceutical, veterinary, dental
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S602/00Surgery: splint, brace, or bandage
    • Y10S602/904Film-forming bandage material

Definitions

  • the present invention is directed to methods for retarding blister formation by use of cyanoacrylate adhesives that can be applied to skin areas prone to blistering prior to blister formation.
  • Cyanoacrylate adhesives have been suggested for a variety of adhesive purposes including glues and surgical adhesives.
  • R is an alkyl or other suitable substituents are disclosed in U.S. Patent Nos. 3,527,224; 3,591,676; 3,667,472; 3,995,641; 4,035,334; and 4,650,826.
  • the R substituent is alkyl of from 2 to 6 carbon atoms and most often is butyl.
  • cyanoacrylate adhesives have been limited to surgical environments wherein the cyanoacrylate adhesives are utilized as an alternative to sutures and are employed in a sterile environment. Specifically, in surgical environments, the cyanoacrylate adhesive is applied to separate sections of soft tissue.
  • the cyanoacrylate adhesive in the presence of water found in soft tissue, bonds to the skin as well as polymerizes so as to join separate sections of soft tissue together.
  • the present invention is a result of the discovery that application of cyanoacrylate adhesives to blister prone areas and subsequent polymerization results in the formation of an artificial callus over the blister prone area thereby retarding the formation of blisters in these areas. More particularly, the application of cyanoacrylate adhesives is only to the surface of the skin and not to cut areas of skin.
  • the present invention is directed to methods for inhibiting blister formation by application of a cyanoacrylate adhesive to the skin area prone to blistering prior to blister formation.
  • the present invention is directed to a method for inhibiting blister formation arising from friction during physical activities which method comprises: applying, either prior to or during physical activities but prior to blister formation, a quantity of cyanoacrylate adhesive to a surface area of uncut skin which is prone to blister formation, which quantity of cyanoacrylate adhesive is sufficient to form an artificial callus; and maintaining the cyanoacrylate adhesive under conditions which polymerize the adhesive thereby forming an artificial callus which adheres to the surface area of uncut skin where the adhesive was applied.
  • the cyanoacrylate, in monomeric form is represented by formula I:
  • R is selected from the group consisting of alkyl of 1 to 10 carbon atoms, alkenyl of 2 to 10 carbon atoms, cycloalkyl groups of from 5 to 8 carbon atoms, phenyl, 2-ethoxyethyl, 3-methoxybutyl, and a substituent of the formula:
  • each R' is independently selected from the group consisting of hydrogen and methyl and R" is selected from the group consisting of alkyl of from 1 to 6 carbon atoms; alkenyl of from 2 to 6 carbon atoms; alkynyl of from 2 to 6 carbon atoms; cycloalkyl of from 3 to 8 carbon atoms; aralkyl selected from the group consisting of benzyl, methylbenzyl and phenylethyl; phenyl; and phenyl substituted with 1 to 3 substituents selected from the group consisting of hydroxy, chloro, bromo, nitro, alkyl of 1 to 4 carbon atoms, and alkoxy of from 1 to 4 carbon atoms.
  • R is alkyl of from 1 to 10 carbon atoms and more preferably alkyl of from 2 to 6 carbon atoms. Most preferably, R is n-butyl.
  • the present invention is directed to a method for inhibiting blister formation arising from friction during physical activities which method comprises: applying, either prior to or during physical activities but prior to blister formation, at least 0.02 milliliter (ml) of cyanoacrylate adhesive per square centimeter of surface area of uncut skin which is prone to blister formation; and - maintaining the cyanoacrylate adhesive under conditions which polymerize the adhesive thereby forming an artificial callus which adheres to the surface area of uncut skin where the adhesive was applied wherein the cyanoacrylate, in monomeric form, is represented by formula II:
  • the cyanoacrylate adhesive to be applied to the skin has a viscosity of from about 2 to about 1000 centipoise at 20°C. More preferably, the cyanoacrylate adhesive is in monomeric form and has a viscosity of from about 2 to about 20 centipoise at 20°C.
  • cyanoacrylate adhesive refers to adhesives based on cyanoacrylate monomers of formula I:
  • R is selected from the group consisting of alkyl of 1 to 10 carbon atoms, alkenyl of 2 to 10 carbon atoms, cycloalkyl groups of from 5 to 8 carbon atoms. phenyl, 2-ethoxyethyl, 3-methoxybutyl, and a substituent of the formula:
  • each R' is independently selected from the group consisting of hydrogen and methyl and R" is selected from the group consisting of alkyl of from 1 to 6 carbon atoms; alkenyl of from 2 to 6 carbon atoms; alkynyl of from 2 to 6 carbon atoms; cycloalkyl of from 3 to 8 carbon atoms; aralkyl selected from the group consisting of benzyl, methylbenzyl and phenylethyl; phenyl; and phenyl substituted with 1 to 3 substituents selected from the group consisting of hydroxy, chloro, bromo, nitro, alkyl of l to 4 carbon atoms, and alkoxy of from 1 to 4 carbon atoms.
  • R is an alkyl group of from 1 to 10 carbon atoms including methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, n-pentyl, iso-pentyl, n-hexyl, iso-hexyl, 2-ethylhexyl, n-heptyl, octyl, nonyl, and decyl. More preferably, R is butyl and most preferably, R is n-butyl.
  • artificial callus refers to a layer of polymerized cyanoacrylate adhesive formed over and strongly adhering to a defined surface area of skin.
  • blister refers to an elevation of the epidermis containing a watery liquid which arises from friction during physical exertion as opposed to some type of disease condition (e.g., chicken pox). Contrarily, the term “blister” does -not refer to irritated skin areas which have not yet blistered (i.e., formed a watery liquid under the epidermis).
  • the cyanoacrylate adhesive can be applied to irritated skin areas prior to blister formation as a means for preventing further irritation and, thereby, for retarding blister formation.
  • the cyanoacrylate adhesive to be applied onto the skin can be monomeric or partially polymeric.
  • partially polymerized cyanoacrylate adhesives are liquid polymers having a higher viscosity than that of the corresponding monomer and, therefore, are better suited for those applications which are intended to be specific for a particular skin area. In other words, less viscous materials are more likely to "run" (i.e., flow) into areas where application was not intended.
  • the cyanoacrylate adhesives used herein preferably have a viscosity of from about 2 to about 1000 centipoise and more preferably from about 2 to about 20 centipoise at 20°C.
  • the specific viscosity of the formulation depends on the amount and degree of partially polymerized cyanoacrylate adhesive employed. Such factors are readily ascertainable by the skilled artisan. For example, methods for preparing partially polymerized cyanoacrylate adhesives are disclosed, for example, by Rabinowitz, U.S. Patent No. 3,527,224. Monomeric forms of cyanoacrylate adhesives are often preferred where application is to be made to a large surface. This preference results from the fact that those forms are less viscous and, accordingly, will permit more facile large surface area application. Mixtures of monomeric forms of cyanoacrylate adhesive and partially polymerized forms of cyanoacrylate adhesive can also be used to prepare a formulation having intermediate viscosities.
  • the cyanoacrylate adhesives Upon contact with skin moisture, the cyanoacrylate adhesives will polymerize or, in the case of partially polymerized cyanoacrylate adhesives, will further polymerize, at ambient conditions (skin temperature) over 10 seconds to 60 seconds to provide for a solid layer which forms over and strongly adheres to the surface of the skin.
  • This polymer layer serves as an artificial callus and protects the underlying skin against blistering in much the same way as does a natural callus.
  • the artificial callus because of its strong binding affinity to skin and because of the durability of the polymerized cyanoacrylate adhesive serves as a substitute for human calluses.
  • sufficient cyanoacrylate adhesive is applied onto the surface of the skin to provide for an artificial callus having sufficient thickness to inhibit blister formation.
  • the artificial callus has a thickness of at least about 0.1 millimeter (mm) and more preferably at least about 0.3 mm.
  • the artificial callus has a thickness ranging from about 0.1 mm to about 0.5 mm and even more preferably from about 0.1 to 0.3 mm. Normally, thicknesses greater than about 0.5 mm are not preferred because shearing forces may disrupt the adhesive formed.
  • the artificial callus is preferably formed by application of at least 0.02 ml of cyanoacrylate adhesive per square centimeter of skin.
  • cyanoacrylate adhesive formulations employed herein generally comprise monomeric and/or partially polymerized compounds of formula I described above. These compositions are liquid in nature and upon contact with skin moisture will polymerize to provide a solid film or layer over the skin surface.
  • the formulations may additionally contain one or more optional additives such as colorants, perfumes, and stabilizers.
  • optional additives such as colorants, perfumes, and stabilizers.
  • each of these optional additives should be both miscible and compatible with the cyanoacrylate adhesive.
  • Compatible additives are those that do not prevent the use of the cyanoacrylate adhesives for their intended use.
  • colorants are added so that the polymerized film will contain a discrete and discernable color.
  • Perfumes are added to provide a pleasant smell to the formulation.
  • Stabilizers are added to minimize in situ polymerization in containers during storage.
  • suitable.stabilizers are disclosed in U.S. Patent No. 4,650,826.
  • the formulation is generally stored in an applicator for use in a single dose application or for use in repeated applications.
  • Single dose applicators include those having breakable or removable seals that prevent moisture, including atmospheric moisture, from contacting the formulation and causing in situ polymerization.
  • the cyanoacrylate adhesive is stored at ambient conditions and is selected to be bacterio ⁇ static. See, for example, Rabinowitz et al., U.S. Patent No. 3,527,224.
  • the selected adhesive is bacteriostatic, prolonged storage at ambient conditions is without regard to the sterility of the formulation because there is no adverse build-up of bacteria during storage.
  • the above-described formulations are applied onto the skin surface area under conditions suitable for polymerizing the adhesive so as to form an artificial callus.
  • sufficient amounts of cyanoacrylate adhesive are employed to permit formation of an artificial callus having a sufficient thickness to inhibit blister formation.
  • the artificial callus has a thickness of at least about 0.1 mm and more preferably at least about 0.3 mm.
  • Such artificial calluses are formed by applying at least about 0.02 ml of cyanoacrylate adhesive per square centimeter of skin surface area and preferably from about 0.02 ml to about 0.5 ml of cyanoacrylate adhesive per square centimeter of skin surface area.
  • the amount of cyanoacrylate adhesive employed does not exceed about 0.05 ml per square centimeter. At concentrations in excess of the maximum preferred concentration, it can, in some cases, take too long for the artificial callus to form, and the resulting callus is subject to shear forces. Additionally, higher concentrations of adhesive create polymers having less than desirable skin adherence and durability characteristics.
  • the amount of cyanoacrylate adhesive applied onto the skin surface area can be controlled by the amount of adhesive packaged in a single dose product or by use of a multiple use dispenser which governs the amount of material applied onto the skin.
  • the dispenser described by Otake, U.S. Patent No. 4,958,748 is particularly advantageous because it dispenses the adhesive in a controlled drop-wise manner.
  • the cyanoacrylate adhesive is applied prior to blister formation. That is, the cyanoacrylate adhesive is applied onto the blister prone areas of the skin prior to initiation of physical activity which would be expected to result in the formation of blisters. Additionally, the cyanoacrylate adhesive can be applied onto blister prone areas at some point during physical activity when blister prone areas begin exhibiting some of the classic signs of blister formation (i.e., irritation, perceived heat and- so forth) .
  • the surface skin moisture and temperature are sufficient to initiate polymerization of the adhesive upon application. Thereafter, the skin surface is maintained under suitable conditions to allow polymerization to proceed to formation of an artificial callus.
  • polymerization is generally complete within about 10 to about 60 seconds while the skin is maintained at ambient conditions. During this period, the person to whom application of the cyanoacrylate adhesive has been made merely allows the adhesive to form a callus while minimizing any action to prevent the adhesive from being dislodged from that portion of the skin where it was applied (e.g., washing his hands, placing socks on his feet) or to adhere to unintended objects (e.g., gripping an object immediately after application of the adhesive) .
  • the callus After the artificial callus has formed, the callus strongly adheres to the skin, is flexible and waterproof thereby permitting the person to conduct the intended activity. In general, the artificial callus will adhere to the skin for a period of about 2-3 days after which time it sloughs off. However, if it is desirable to remove the artificial callus prior to its sloughing off, the artificial callus can be removed with acetone (nail polish remover) .
  • the methods of this invention are useful in retarding the formation of blisters.
  • the methods of this invention result in the formation of artificial calluses which inhibit blister formation.
  • the methods of this invention are particularly suited for retarding blister formation in people who are prone to blister formation.
  • Example 1 A cyanoacrylate adhesive formulation was prepared in monomeric form using n-butyl ⁇ -cyano- acrylate of formula II above. The formulation was placed into the dispensing device described by Otake, U.S. Patent No. 4,958,748. Three drops of the formulation were placed drop-wise onto the palm of the hand in an area prone to blister formation of about 2 square centimeters in area so as to provide about 0.02 ml of adhesive per square centimeter. The hand was held palm up for about 1 minute. At this time an artificial callus had formed over this surface.

Abstract

A cyanoacrylate adhesive is applied to the skin areas prone to blistering either prior to or during physical activities but prior to blister formation.

Description

METHODS FOR RETARDING BLISTER FORMATION BY USE OF CYANOACRYLATE ADHESIVES
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention is directed to methods for retarding blister formation by use of cyanoacrylate adhesives that can be applied to skin areas prone to blistering prior to blister formation.
State of the Art
Cyanoacrylate adhesives have been suggested for a variety of adhesive purposes including glues and surgical adhesives. In particular, cyanoacrylate adhesives of formula I:
Figure imgf000003_0001
wherein R is an alkyl or other suitable substituents are disclosed in U.S. Patent Nos. 3,527,224; 3,591,676; 3,667,472; 3,995,641; 4,035,334; and 4,650,826. Typically, when used as adhesives for living tissues, the R substituent is alkyl of from 2 to 6 carbon atoms and most often is butyl.
The suggested medical uses for cyanoacrylate adhesives have been limited to surgical environments wherein the cyanoacrylate adhesives are utilized as an alternative to sutures and are employed in a sterile environment. Specifically, in surgical environments, the cyanoacrylate adhesive is applied to separate sections of soft tissue. The cyanoacrylate adhesive. in the presence of water found in soft tissue, bonds to the skin as well as polymerizes so as to join separate sections of soft tissue together.
SUMMARY OF THE INVENTION
The present invention, generally speaking, is a result of the discovery that application of cyanoacrylate adhesives to blister prone areas and subsequent polymerization results in the formation of an artificial callus over the blister prone area thereby retarding the formation of blisters in these areas. More particularly, the application of cyanoacrylate adhesives is only to the surface of the skin and not to cut areas of skin.
Thus, it can be understood that the present invention is directed to methods for inhibiting blister formation by application of a cyanoacrylate adhesive to the skin area prone to blistering prior to blister formation. Accordingly, in one of its method aspects, the present invention is directed to a method for inhibiting blister formation arising from friction during physical activities which method comprises: applying, either prior to or during physical activities but prior to blister formation, a quantity of cyanoacrylate adhesive to a surface area of uncut skin which is prone to blister formation, which quantity of cyanoacrylate adhesive is sufficient to form an artificial callus; and maintaining the cyanoacrylate adhesive under conditions which polymerize the adhesive thereby forming an artificial callus which adheres to the surface area of uncut skin where the adhesive was applied. wherein the cyanoacrylate, in monomeric form, is represented by formula I:
Figure imgf000005_0001
where R is selected from the group consisting of alkyl of 1 to 10 carbon atoms, alkenyl of 2 to 10 carbon atoms, cycloalkyl groups of from 5 to 8 carbon atoms, phenyl, 2-ethoxyethyl, 3-methoxybutyl, and a substituent of the formula:
Figure imgf000005_0002
where each R' is independently selected from the group consisting of hydrogen and methyl and R" is selected from the group consisting of alkyl of from 1 to 6 carbon atoms; alkenyl of from 2 to 6 carbon atoms; alkynyl of from 2 to 6 carbon atoms; cycloalkyl of from 3 to 8 carbon atoms; aralkyl selected from the group consisting of benzyl, methylbenzyl and phenylethyl; phenyl; and phenyl substituted with 1 to 3 substituents selected from the group consisting of hydroxy, chloro, bromo, nitro, alkyl of 1 to 4 carbon atoms, and alkoxy of from 1 to 4 carbon atoms.
Preferably R is alkyl of from 1 to 10 carbon atoms and more preferably alkyl of from 2 to 6 carbon atoms. Most preferably, R is n-butyl.
In another of its method aspects, the present invention is directed to a method for inhibiting blister formation arising from friction during physical activities which method comprises: applying, either prior to or during physical activities but prior to blister formation, at least 0.02 milliliter (ml) of cyanoacrylate adhesive per square centimeter of surface area of uncut skin which is prone to blister formation; and - maintaining the cyanoacrylate adhesive under conditions which polymerize the adhesive thereby forming an artificial callus which adheres to the surface area of uncut skin where the adhesive was applied wherein the cyanoacrylate, in monomeric form, is represented by formula II:
0
Figure imgf000006_0001
In a preferred embodiment, the cyanoacrylate adhesive to be applied to the skin has a viscosity of from about 2 to about 1000 centipoise at 20°C. More preferably, the cyanoacrylate adhesive is in monomeric form and has a viscosity of from about 2 to about 20 centipoise at 20°C.
As used herein, the following terms have the following meanings:
The term "cyanoacrylate adhesive" refers to adhesives based on cyanoacrylate monomers of formula I:
O
CH2=C-C IIOR
Figure imgf000006_0002
where R is selected from the group consisting of alkyl of 1 to 10 carbon atoms, alkenyl of 2 to 10 carbon atoms, cycloalkyl groups of from 5 to 8 carbon atoms. phenyl, 2-ethoxyethyl, 3-methoxybutyl, and a substituent of the formula:
Figure imgf000007_0001
where each R' is independently selected from the group consisting of hydrogen and methyl and R" is selected from the group consisting of alkyl of from 1 to 6 carbon atoms; alkenyl of from 2 to 6 carbon atoms; alkynyl of from 2 to 6 carbon atoms; cycloalkyl of from 3 to 8 carbon atoms; aralkyl selected from the group consisting of benzyl, methylbenzyl and phenylethyl; phenyl; and phenyl substituted with 1 to 3 substituents selected from the group consisting of hydroxy, chloro, bromo, nitro, alkyl of l to 4 carbon atoms, and alkoxy of from 1 to 4 carbon atoms.
Preferably, R is an alkyl group of from 1 to 10 carbon atoms including methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, n-pentyl, iso-pentyl, n-hexyl, iso-hexyl, 2-ethylhexyl, n-heptyl, octyl, nonyl, and decyl. More preferably, R is butyl and most preferably, R is n-butyl.
These cyanoacrylate adhesives are known in the art and are described in, for example, U.S. Patent Nos. 3,527,224; 3,591,676; 3,667,472; 3,995,641; 4,035,334; and 4,650,826.
The term "artificial callus" refers to a layer of polymerized cyanoacrylate adhesive formed over and strongly adhering to a defined surface area of skin. The term "blister" refers to an elevation of the epidermis containing a watery liquid which arises from friction during physical exertion as opposed to some type of disease condition (e.g., chicken pox). Contrarily, the term "blister" does -not refer to irritated skin areas which have not yet blistered (i.e., formed a watery liquid under the epidermis). In this invention, the cyanoacrylate adhesive can be applied to irritated skin areas prior to blister formation as a means for preventing further irritation and, thereby, for retarding blister formation.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The cyanoacrylate adhesive to be applied onto the skin can be monomeric or partially polymeric. In general, partially polymerized cyanoacrylate adhesives are liquid polymers having a higher viscosity than that of the corresponding monomer and, therefore, are better suited for those applications which are intended to be specific for a particular skin area. In other words, less viscous materials are more likely to "run" (i.e., flow) into areas where application was not intended.
The cyanoacrylate adhesives used herein preferably have a viscosity of from about 2 to about 1000 centipoise and more preferably from about 2 to about 20 centipoise at 20°C. The specific viscosity of the formulation depends on the amount and degree of partially polymerized cyanoacrylate adhesive employed. Such factors are readily ascertainable by the skilled artisan. For example, methods for preparing partially polymerized cyanoacrylate adhesives are disclosed, for example, by Rabinowitz, U.S. Patent No. 3,527,224. Monomeric forms of cyanoacrylate adhesives are often preferred where application is to be made to a large surface. This preference results from the fact that those forms are less viscous and, accordingly, will permit more facile large surface area application. Mixtures of monomeric forms of cyanoacrylate adhesive and partially polymerized forms of cyanoacrylate adhesive can also be used to prepare a formulation having intermediate viscosities.
Upon contact with skin moisture, the cyanoacrylate adhesives will polymerize or, in the case of partially polymerized cyanoacrylate adhesives, will further polymerize, at ambient conditions (skin temperature) over 10 seconds to 60 seconds to provide for a solid layer which forms over and strongly adheres to the surface of the skin. This polymer layer serves as an artificial callus and protects the underlying skin against blistering in much the same way as does a natural callus.
The artificial callus, because of its strong binding affinity to skin and because of the durability of the polymerized cyanoacrylate adhesive serves as a substitute for human calluses.
In general, sufficient cyanoacrylate adhesive is applied onto the surface of the skin to provide for an artificial callus having sufficient thickness to inhibit blister formation. In a preferred embodiment, the artificial callus has a thickness of at least about 0.1 millimeter (mm) and more preferably at least about 0.3 mm. In another preferred embodiment, the artificial callus has a thickness ranging from about 0.1 mm to about 0.5 mm and even more preferably from about 0.1 to 0.3 mm. Normally, thicknesses greater than about 0.5 mm are not preferred because shearing forces may disrupt the adhesive formed.
In another preferred embodiment, the artificial callus is preferably formed by application of at least 0.02 ml of cyanoacrylate adhesive per square centimeter of skin.
Various parts of the human body are prone to blister formation, including the grip portions of hands and the base of feet. During physical exertion, these parts of the body can be subject to friction by such activities as walking/jogging (feet) , shoveling (hands) . The all too familiar result of such activities, particularly in people not accustomed to such activities, is the formation of blisters in those areas prone to blister formation.
Formulations The cyanoacrylate adhesive formulations employed herein generally comprise monomeric and/or partially polymerized compounds of formula I described above. These compositions are liquid in nature and upon contact with skin moisture will polymerize to provide a solid film or layer over the skin surface.
The formulations may additionally contain one or more optional additives such as colorants, perfumes, and stabilizers. In practice, each of these optional additives should be both miscible and compatible with the cyanoacrylate adhesive. Compatible additives are those that do not prevent the use of the cyanoacrylate adhesives for their intended use.
In general, colorants are added so that the polymerized film will contain a discrete and discernable color. Perfumes are added to provide a pleasant smell to the formulation. Stabilizers are added to minimize in situ polymerization in containers during storage. Each of these additives are conventional. For example, suitable.stabilizers are disclosed in U.S. Patent No. 4,650,826.
The formulation is generally stored in an applicator for use in a single dose application or for use in repeated applications. Single dose applicators include those having breakable or removable seals that prevent moisture, including atmospheric moisture, from contacting the formulation and causing in situ polymerization.
For repeated and intermittent usage, minimal exposure to atmospheric moisture is required. This can be achieved by devices having very narrow outlets and low initial deadspace. One applicator for such repeated intermittent use is described in U.S. Patent No. 4,958,748.
In applicators suitable for repeated intermittent uses, the cyanoacrylate adhesive is stored at ambient conditions and is selected to be bacterio¬ static. See, for example, Rabinowitz et al., U.S. Patent No. 3,527,224. When the selected adhesive is bacteriostatic, prolonged storage at ambient conditions is without regard to the sterility of the formulation because there is no adverse build-up of bacteria during storage.
Methodology The above-described formulations are applied onto the skin surface area under conditions suitable for polymerizing the adhesive so as to form an artificial callus. In general, sufficient amounts of cyanoacrylate adhesive are employed to permit formation of an artificial callus having a sufficient thickness to inhibit blister formation. In a preferred embodiment, the artificial callus has a thickness of at least about 0.1 mm and more preferably at least about 0.3 mm. Such artificial calluses are formed by applying at least about 0.02 ml of cyanoacrylate adhesive per square centimeter of skin surface area and preferably from about 0.02 ml to about 0.5 ml of cyanoacrylate adhesive per square centimeter of skin surface area.
In another preferred embodiment, the amount of cyanoacrylate adhesive employed does not exceed about 0.05 ml per square centimeter. At concentrations in excess of the maximum preferred concentration, it can, in some cases, take too long for the artificial callus to form, and the resulting callus is subject to shear forces. Additionally, higher concentrations of adhesive create polymers having less than desirable skin adherence and durability characteristics.
The amount of cyanoacrylate adhesive applied onto the skin surface area can be controlled by the amount of adhesive packaged in a single dose product or by use of a multiple use dispenser which governs the amount of material applied onto the skin. In this regard, the dispenser described by Otake, U.S. Patent No. 4,958,748 is particularly advantageous because it dispenses the adhesive in a controlled drop-wise manner.
For inhibiting the formation of blisters, the cyanoacrylate adhesive is applied prior to blister formation. That is, the cyanoacrylate adhesive is applied onto the blister prone areas of the skin prior to initiation of physical activity which would be expected to result in the formation of blisters. Additionally, the cyanoacrylate adhesive can be applied onto blister prone areas at some point during physical activity when blister prone areas begin exhibiting some of the classic signs of blister formation (i.e., irritation, perceived heat and- so forth) .
Upon application of the cyanoacrylate adhesive, the surface skin moisture and temperature are sufficient to initiate polymerization of the adhesive upon application. Thereafter, the skin surface is maintained under suitable conditions to allow polymerization to proceed to formation of an artificial callus.
In general, the particular length of time required for polymerization will vary depending upon factors such as the amount of adhesive applied, the temperature of the skin, the moisture content of the skin and the like. However, in a preferred embodiment, polymerization is generally complete within about 10 to about 60 seconds while the skin is maintained at ambient conditions. During this period, the person to whom application of the cyanoacrylate adhesive has been made merely allows the adhesive to form a callus while minimizing any action to prevent the adhesive from being dislodged from that portion of the skin where it was applied (e.g., washing his hands, placing socks on his feet) or to adhere to unintended objects (e.g., gripping an object immediately after application of the adhesive) . After the artificial callus has formed, the callus strongly adheres to the skin, is flexible and waterproof thereby permitting the person to conduct the intended activity. In general, the artificial callus will adhere to the skin for a period of about 2-3 days after which time it sloughs off. However, if it is desirable to remove the artificial callus prior to its sloughing off, the artificial callus can be removed with acetone (nail polish remover) .
It can now be understood that the methods of this invention are useful in retarding the formation of blisters. In particular, the methods of this invention result in the formation of artificial calluses which inhibit blister formation. As such, the methods of this invention are particularly suited for retarding blister formation in people who are prone to blister formation.
The following example illustrates certain embodiments of the invention but is not meant to limit the scope of the claims in any way.
Example 1 A cyanoacrylate adhesive formulation was prepared in monomeric form using n-butyl α-cyano- acrylate of formula II above. The formulation was placed into the dispensing device described by Otake, U.S. Patent No. 4,958,748. Three drops of the formulation were placed drop-wise onto the palm of the hand in an area prone to blister formation of about 2 square centimeters in area so as to provide about 0.02 ml of adhesive per square centimeter. The hand was held palm up for about 1 minute. At this time an artificial callus had formed over this surface.
From the foregoing description, various modifications and changes in the composition and method will occur to those skilled in the art. All such modifications coming within the scope of the appended claims are intended to be included therein.

Claims

WHAT IS CLAIMED IS:
1. A method for inhibiting blister formation arising from friction during physical activities which method comprises: applying, either prior to or during physical activities but prior to blister formation, a quantity of cyanoacrylate adhesive to a surface area of uncut skin which is prone to blister formation, which quantity of cyanoacrylate adhesive is sufficient to form an artificial callus; and maintaining the cyanoacrylate adhesive under conditions which polymerize the adhesive thereby forming an artificial callus which adheres to the surface area of uncut skin where the adhesive was applied; wherein the cyanoacrylate, in monomeric form, is represented by formula I:
Figure imgf000016_0001
where R is selected from the group consisting of alkyl of 1 to 10 carbon atoms, alkenyl of 2 to 10 carbon atoms, cycloalkyl groups of from 5 to 8 carbon atoms, phenyl, 2-ethoxyethyl, 3-methoxybutyl, and a substituent of the formula:
Figure imgf000016_0002
where each R' is independently selected from the group consisting of hydrogen and methyl and R" is selected from the group consisting of alkyl of from 1 to 6 carbon atoms; alkenyl of from 2 to 6 carbon atoms; alkynyl of from 2 to 6 carbon atoms; cycloalkyl of from 3 to 8 carbon atoms; aralkyl selected from the group consisting of benzyl, methylbenzyl and phenylethyl; phenyl; and phenyl substituted with 1 to 3 substituents selected from the group consisting of hydroxy, chloro, bromo, nitro, alkyl of 1 to 4 carbon atoms, and alkoxy of from 1 to 4 carbon atoms.
2. A method according to Claim 1 wherein R is alkyl of from 2 to 6 carbon atoms.
3. A method according to Claim 2 wherein R is butyl.
4. A method according to Claim 3 wherein R is n-butyl.
5. A method for inhibiting blister formation arising from friction during physical activities which method comprises: applying, either prior to or during physical activities but prior to blister formation, at least 0.02 ml of cyanoacrylate adhesive per square centimeter of surface area of uncut skin which is prone to blister formation; and maintaining the cyanoacrylate adhesive under conditions which polymerize the adhesive thereby forming an artificial callus which adheres to the surface area of uncut skin where the adhesive was applied wherein the cyanoacrylate, in monomeric form, is represented by formula II:
O CH2=C-C IIO(CH2)3CH3. II
CN
6. The method according to Claim 1 wherein the cyanoacrylate adhesive has a viscosity of from about 2 to about 1000 centipoise at 20°C.
7. The method according to Claim 6 wherein the cyanoacrylate adhesive has a viscosity of from about 2 to about 20 centipoise at 20°C.
8. The method according to Claim 5 wherein the cyanoacrylate adhesive has a viscosity of from about 2 to about 1000 centipoise at 20°C.
9. The method according to Claim 8 wherein the cyanoacrylate adhesive has a viscosity of from about 2 to about 20 centipoise at 20°C.
10. The method according to Claim 1 wherein the cyanoacrylate adhesive is applied at a concentration of at least 0.02 ml per square centimeter of surface area of uncut skin.
11. The method according to Claim 5 wherein the cyanoacrylate adhesive is applied at a concentration of from about 0.02 ml to about 0.05 ml per square centimeter of surface area of uncut skin.
12. The method of Claim 10 wherein the cyanoacrylate adhesive is applied at a concentration of from about 0.02 ml to about 0.05 ml per square centimeter of surface area of uncut skin.
13. The method of Claim 1 wherein the cyanoacrylate adhesive is polymerized by maintaining the cyanoacrylate adhesive on the uncut skin surface for a period of from about 10 to 60 seconds and at ambient skin temperature.
14. The method of Claim 5 wherein the cyanoacrylate adhesive is polymerized by maintaining the cyanoacrylate adhesive on the uncut skin surface for a period of from about 10 to 60 seconds and at ambient skin temperature.
PCT/US1993/003716 1992-04-20 1993-04-20 Methods for retarding blister formation by use of cyanoacrylate adhesives WO1993020829A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/871,558 US5306490A (en) 1992-04-20 1992-04-20 Methods for retarding blister formation by use of cyanoacrylate adhesives
US07/871,558 1992-04-20

Publications (1)

Publication Number Publication Date
WO1993020829A1 true WO1993020829A1 (en) 1993-10-28

Family

ID=25357705

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/003716 WO1993020829A1 (en) 1992-04-20 1993-04-20 Methods for retarding blister formation by use of cyanoacrylate adhesives

Country Status (3)

Country Link
US (1) US5306490A (en)
AU (1) AU4033093A (en)
WO (1) WO1993020829A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062331A1 (en) * 2001-01-16 2002-08-15 Hans Brinch Lyster Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342213B1 (en) * 1992-06-09 2002-01-29 Medlogic Global Corporation Methods for treating non-suturable wounds by use of cyanoacrylate adhesives
WO1995022998A1 (en) * 1994-02-24 1995-08-31 Medlogic Global Corporation Methods for reducing skin irritation from artificial devices by use of cyanoacrylate adhesives
US6492434B1 (en) * 1994-06-23 2002-12-10 Flowers Park Ltd. Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives
US5480935A (en) * 1994-09-01 1996-01-02 Medlogic Global Corporation Cyanoacrylate adhesive compositions
US5580565A (en) * 1994-09-01 1996-12-03 Medlogic Global Corporation Use of cyanoacrylate adhesives for providing a protective barrier film for the skin
US5650138A (en) * 1995-03-15 1997-07-22 Resler; Renee Composition and method for applying protective coating on a nail surface
US5554365A (en) * 1995-05-05 1996-09-10 Medlogic Global Corporation Use of cyanoacrylate adhesive compositions to inhibit acute radiation-induced skin damage
US6217603B1 (en) 1997-08-29 2001-04-17 Closure Medical Corporation Methods of applying monomeric compositions effective as wound closure devices
US5981621A (en) * 1996-02-29 1999-11-09 Closure Medical Corporation Monomeric compositions effective as wound closure devices
US20020018689A1 (en) * 1995-06-07 2002-02-14 Badejo Ibraheem T. Adhesive applicators with improved polymerization initiators
CA2317413A1 (en) * 1997-01-10 1998-07-16 Medlogic Global Corporation Cyanoacrylate compositions comprising an antimicrobial agent
WO1998030093A1 (en) * 1997-01-10 1998-07-16 Medlogic Global Corporation Methods for draping surgical incision sites
US5684042A (en) * 1997-01-10 1997-11-04 Medlogic Global Corporation Cyanoacrylate compositions comprising an antimicrobial agent
US5730994A (en) * 1997-01-10 1998-03-24 Medlogic Global Corporation Methods for draping surgical incision sites
AU4911297A (en) * 1997-01-10 1998-08-03 Medlogic Global Corporation Methods for treating non-suturable, superficial wounds by use of cyanoacrylat e ester compositions comprising an antimicrobial agent
US5957877A (en) * 1997-11-03 1999-09-28 Medlogic Global Corporation Methods for draping surgical sites using peripheral cyanoacrylate drapes
US6001345A (en) * 1997-11-03 1999-12-14 Medlogic Global Corporation Application of cyanoacrylate/anti-microbial compositions to the peri-wound or peri-mucosal area
WO2000072761A1 (en) 1999-05-29 2000-12-07 Tyco Health Care Group, Lp Bioabsorbable blends and surgical articles therefrom
US6352704B1 (en) 1999-06-30 2002-03-05 Closure Medical Corporation Flavored cyanoacrylate compositions
US6479725B1 (en) 2000-06-30 2002-11-12 Lisa M. Brothers Method of treatment of a wound or incision
AU2001283512A1 (en) 2000-07-27 2002-02-13 Flowers Park Limited Methods for treating burns on mammalian skin to reduce the risk of infection andto minimize fluid loss
US6521221B2 (en) 2000-11-06 2003-02-18 Flowers Park Ltd. Methods and compositions to enable the safe and effective harvesting of tissues and organs
US6942875B2 (en) * 2001-07-05 2005-09-13 Closure Medical Corporation Adhesive treatment for skin yeast infections
US6767552B2 (en) 2001-07-05 2004-07-27 Closure Medical Corporation Adhesive treatment for oral fungal infection
US6602496B2 (en) 2001-07-05 2003-08-05 Closure Medical Corporation Adhesive treatment for tinea corporis
US6746667B2 (en) 2001-07-05 2004-06-08 Closure Medical Corporation Adhesive treatment for tinea pedis
US6585967B2 (en) 2001-07-05 2003-07-01 Closure Medical Corporation Adhesive treatment for tinea cruris
WO2003011261A1 (en) * 2001-08-01 2003-02-13 Medlogic Global Limited Cyanoacrylate monomer-containing antibiotic formulation for topical use
WO2003041686A2 (en) * 2001-11-14 2003-05-22 Medlogic Global Limited Improved therapy for topical diseases
US7255874B1 (en) 2001-12-21 2007-08-14 Closure Medical Corporation Biocompatible polymers and adhesives: compositions, methods of making and uses related thereto
WO2005000985A2 (en) * 2003-06-03 2005-01-06 Medlogic Global Limited Antimicrobial phenol containing cyanoacrylate adhesive compositions
US20050197421A1 (en) * 2004-03-03 2005-09-08 Loomis Gary L. Process for preparation of cyanoacrylate compositions
US20080167592A1 (en) * 2006-10-26 2008-07-10 Greer Steven E Preventing or treating wounds with a collodion barrier incorporating active agents
US20080152614A1 (en) * 2006-12-22 2008-06-26 3M Innovative Properties Company Method and kit for skin lesion prevention and/or protection
US8729121B2 (en) 2007-06-25 2014-05-20 Adhezion Biomedical, Llc Curing accelerator and method of making
WO2010008822A2 (en) 2008-06-23 2010-01-21 Adhezion Biomedical, Llc Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
US20090098073A1 (en) * 2007-10-12 2009-04-16 Macdonald John Gavin Phase change visual indicating composition
US20090098081A1 (en) * 2007-10-12 2009-04-16 Macdonald John Gavin System for providing a method for applying a skin sealant having a phase change visual indicating component
US20090123569A1 (en) * 2007-11-08 2009-05-14 Macdonald John Gavin Coverage indicating technology for skin sealants using tannates
US8613952B2 (en) * 2007-11-14 2013-12-24 Adhezion Biomedical, Llc Cyanoacrylate tissue adhesives
US8198344B2 (en) * 2008-06-20 2012-06-12 Adhezion Biomedical, Llc Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
US8293838B2 (en) * 2008-06-20 2012-10-23 Adhezion Biomedical, Llc Stable and sterile tissue adhesive composition with a controlled high viscosity
US8609128B2 (en) * 2008-10-31 2013-12-17 Adhezion Biomedical, Llc Cyanoacrylate-based liquid microbial sealant drape
US8652510B2 (en) 2008-10-31 2014-02-18 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
US9254133B2 (en) 2008-10-31 2016-02-09 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
US9309019B2 (en) 2010-05-21 2016-04-12 Adhezion Biomedical, Llc Low dose gamma sterilization of liquid adhesives
US10543127B2 (en) 2013-02-20 2020-01-28 Cytrellis Biosystems, Inc. Methods and devices for skin tightening
PT2991600T (en) * 2013-05-03 2018-11-05 Cytrellis Biosystems Inc Microclosures and related methods for skin treatment
JP2016529000A (en) 2013-08-09 2016-09-23 サイトレリス バイオシステムズ,インコーポレーテッド Method and apparatus for skin treatment using non-thermal tissue ablation
US10953143B2 (en) 2013-12-19 2021-03-23 Cytrellis Biosystems, Inc. Methods and devices for manipulating subdermal fat
US9421297B2 (en) 2014-04-02 2016-08-23 Adhezion Biomedical, Llc Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides
WO2016077759A1 (en) 2014-11-14 2016-05-19 Cytrellis Biosystems, Inc. Devices and methods for ablation of the skin
AU2017245174A1 (en) 2016-03-29 2018-10-04 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
WO2018057630A1 (en) 2016-09-21 2018-03-29 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2804073A (en) * 1953-01-26 1957-08-27 Protective Teatments Inc Fluid surgical dressing
US3667472A (en) * 1961-10-19 1972-06-06 Borden Inc Adhesive for living tissue
US3527224A (en) * 1967-09-05 1970-09-08 American Cyanamid Co Method of surgically bonding tissue together
US3591676A (en) * 1968-11-01 1971-07-06 Eastman Kodak Co Surgical adhesive compositions
GB1413132A (en) * 1972-10-20 1975-11-05 Vni I Ispygatelny I Med Tekhn Surgical adhesive
US3995641A (en) * 1975-04-23 1976-12-07 Ethicon, Inc. Surgical adhesives
US4444933A (en) * 1982-12-02 1984-04-24 Borden, Inc. Adhesive cyanoacrylate compositions with reduced adhesion to skin
DE3414805A1 (en) * 1984-04-19 1985-10-24 Bayer Ag, 5090 Leverkusen STABILIZED ADHESIVES
EP0367874B1 (en) * 1988-11-08 1992-04-22 Sekisui-Iko Company Ltd. Adhesive applicator

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARCHIVES OF DERMATOLOGY, Vol. 107, 1973, (AKERS), "Treating Friction Blisters with Alkyl-Alpha-Cyanoacrylates", pages 544-547. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062331A1 (en) * 2001-01-16 2002-08-15 Hans Brinch Lyster Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue

Also Published As

Publication number Publication date
AU4033093A (en) 1993-11-18
US5306490A (en) 1994-04-26

Similar Documents

Publication Publication Date Title
US5306490A (en) Methods for retarding blister formation by use of cyanoacrylate adhesives
US5403591A (en) Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives
US6342213B1 (en) Methods for treating non-suturable wounds by use of cyanoacrylate adhesives
US5653769A (en) Methods for reducing skin irritation from artificial devices by use of cyanoacrylate adhesives
US5580565A (en) Use of cyanoacrylate adhesives for providing a protective barrier film for the skin
AU2006279369B2 (en) Conformable solvent-based bandage and coating material
EP0778863B1 (en) Cyanoacrylate adhesive compositions
US20060210528A1 (en) Therapy for tropical diseases
WO1993025196A1 (en) Methods for treating non-suturable wounds by use of cyanoacrylate adhesives
EP0376533B1 (en) Topical application of medicament in a binder
US6492434B1 (en) Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives
US20080152614A1 (en) Method and kit for skin lesion prevention and/or protection
WO1993020828A1 (en) Methods for the multiple, intermittent, non-sterile use of cyanoacrylate adhesives
NZ584498A (en) Conformable solvent-based bandage and coating material comprising cyanoacrylate and a volatile liquid
EP0949933A1 (en) Use of cyanoacrylate adhesives for providing a protective barrier film for the skin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA